BiomX Past Earnings Performance

Past criteria checks 0/6

BiomX has been growing earnings at an average annual rate of 1.4%, while the Biotechs industry saw earnings growing at 19.3% annually.

Key information

1.4%

Earnings growth rate

46.6%

EPS growth rate

Biotechs Industry Growth17.0%
Revenue growth raten/a
Return on equity-23.0%
Net Marginn/a
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

What Kind Of Shareholders Own BiomX Inc. (NYSEMKT:PHGE)?

Jan 29
What Kind Of Shareholders Own BiomX Inc. (NYSEMKT:PHGE)?

Revenue & Expenses Breakdown

How BiomX makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NYSEAM:PHGE Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 240-91220
30 Jun 240-221118
31 Mar 240-341015
31 Dec 230-261016
30 Sep 230-27916
30 Jun 230-251014
31 Mar 230-271015
31 Dec 220-281115
30 Sep 220-331119
30 Jun 220-361222
31 Mar 220-361221
31 Dec 210-361222
30 Sep 210-351222
30 Jun 210-341121
31 Mar 210-331021
31 Dec 200-301019
30 Sep 200-271118
30 Jun 200-231115
31 Mar 200-221014
31 Dec 190-21913
30 Sep 190-22511
30 Jun 190-19411
31 Mar 190-17410
31 Dec 180-1539
31 Dec 170-734

Quality Earnings: PHGE is currently unprofitable.

Growing Profit Margin: PHGE is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: PHGE is unprofitable, but has reduced losses over the past 5 years at a rate of 1.4% per year.

Accelerating Growth: Unable to compare PHGE's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: PHGE is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (16.6%).


Return on Equity

High ROE: PHGE has a negative Return on Equity (-22.97%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 22:41
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

BiomX Inc. is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kristen KluskaCantor Fitzgerald & Co.
Joseph PantginisH.C. Wainwright & Co.
I-Eh JenLaidlaw & Company (UK) Ltd